Evans, Brian C <br/><br/>
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.  [electronic resource] 

 -  Science translational medicine  Jun 2015 
 - 291ra95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aaa4549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Endocytosis--drug effects<br/>Endosomes--drug effects<br/>Humans<br/>Hyperplasia<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Lysosomes--drug effects<br/>Male<br/>Myocytes, Smooth Muscle--drug effects<br/>Nanoparticles--chemistry<br/>Peptides--pharmacology<br/>Phenotype<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Rabbits<br/>Saphenous Vein--drug effects<br/>Treatment Outcome<br/>Tunica Intima--drug effects<br/>Vascular Grafting